Rigel Pharmaceuticals, Inc.

US$39.65As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RIGLHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 4.30%
Div yield —
ROE 109.18%
Biotechnology
Beta (5Y) 1.24
PE TTM 2.578
TSR TTM 25.55%
Mkt cap US$746.6M
ROIC 20.93%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$49
22.57%
(87.27%)
Hold 12|10|7|7|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.43
0.42
0.45
0.46
20.50%
12.49%
17.68%
9.13%
Revenue$M
35.14
36.65
38.17
38.58
3.78%
3.97%
9.63%
10.63%
Peers (US$746.6M)
Cap (US$)
PE
760.3M
—
733.7M
—
Capital
TTM
5Y
10Y
Leveragex
1.139
0.952
0.764
EBIT/Intx
1.532
0.241
0.198
Own earn%
6.62
(16.05)
(28.08)
Sh yield%
35.90
57.89
57.43
Owners
Insiders/Inst%
7.19
52.59
Short interest%
3.59
SBC / revenue%
3.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
8–14
$1 testx
—
Incr. ROIC%
9